Примери за използване на Synagis на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Solvent for Synagis.
What Synagis contains.
How to store Synagis.
Why has Synagis been approved?
How to store Synagis 6.
SYNAGIS 50 mg Outer Carton.
Other medicines and Synagis.
Synagis is a white to off-white cake.
For information on reconstituting Synagis, see section 6.6.
Synagis is not indicated for use in adults.
What do you need to know before Synagis is given to your child.
Synagis Water for injections ampoule label.
The active substance in Synagis, palivizumab, is a monoclonal antibody.
SYNAGIS Water for injections Ampoule Label Text.
The active substance in Synagis, palivizumab, is a monoclonal antibody.
Synagis 100 mg/1 ml solution for injection palivizumab.
What side effects may occur while taking Synagis?
Ml of Synagis solution contains 100 mg of palivizumab*.
If your child has any bleeding disorders as Synagis is usually injected into the thigh.
Synagis is not known to interact with other medicines.
The RSV hospitalisation rate was 9.7% in the placebo group and 5.3% in the Synagis group.
Synagis solution for injection is a ready to use formulation.
However, you should inform your doctor of all medicines your child is currently taking before starting Synagis.
Synagis 50 mg powder for solution for injection Palivizumab.
In a placebo-controlled trial of RSV disease prophylaxis in(IMpact-RSV trial)1502 high-risk children(1002 Synagis; 500 placebo), 5 monthly doses of 15 mg/kg reduced the incidence of RSV related hospitalisation by 55%(p=< 0.001).
SYNAGIS 50 mg powder and solvent for solution for injection Palivizumab.
In a placebo-controlled trial in 1,287 patients 24 months of age with haemodynamically significant congenital heart disease(639 Synagis; 648 placebo), 5 monthly doses of 15 mg/kg Synagis reduced the incidence of RSV hospitalisations by 45%(p= 0.003)(congenital heart disease study).
One vial of Synagis powder and one ampoule of water for injections per pack.
SYNAGIS 100 mg powder for solution for injection Palivizumab Intramuscular.
SYNAGIS 50 mg powder for solution for injection Palivizumab Intramuscular use.